For a veteran whose service meets the VA’s herbicide exposure criteria, a Hodgkin’s disease diagnosis is treated as service-connected without any need to link the cancer to Agent Orange medically. The VA already accepts that link and pays the disability at 100 percent while it is active and during treatment.
Hill & Ponton reviewed 5 years of Board of Veterans’ Appeals decisions and found that Hodgkin’s cases related to Agent Orange are sent back for additional evidence more often than they are granted outright. The claims that are remanded usually stall over a single question: whether the record proves qualifying exposure.
The Agent Orange VA Presumption for Hodgkin’s Disease
Hodgkin’s disease, or Hodgkin’s lymphoma, is one of VA’s Agent Orange presumptive conditions. When a veteran’s service satisfies the VA’s exposure criteria, the agency treats both the exposure and its causal tie to the cancer as settled, so a nexus opinion is unnecessary. That leaves the veteran two things to show: qualifying service and a medically confirmed Hodgkin’s diagnosis.
The presumption is based on National Academies of Sciences, Engineering, and Medicine Veterans and Agent Orange reports which concluded that there is sufficient evidence of an association between herbicide exposure and Hodgkin’s disease. Although the available research on Hodgkin’s is much more limited than the research on non-Hodgkin lymphoma, the findings have been sufficiently consistent to keep Hodgkin’s disease in the highest evidence category.
Which Veterans Qualify for the Presumption?
The VA presumes herbicide exposure for veterans who served in the Republic of Vietnam and in other locations and dates recognized by the VA, including Blue Water Navy sailors in the offshore waters (the Hill & Ponton Blue Water Navy ship locator can help identify if a ship qualifies).
Veterans whose service doesn’t qualify, such as those exposed to herbicide testing or storage at a base inside the United States, can still pursue direct service connection by documenting the actual exposure. The herbicide presumption that allows veterans to forgo proving the medical link will still apply once the direct exposure to Agent Orange is established.
Learn How To File And Win Your VA Claim
Get our FREE book The Road to VA Compensation Benefits.
get the free book
Winning an Agent Orange Hodgkin’s Claim
Because herbicide exposure is what delays or defeats most Hodgkin’s claims, that piece of the file requires the most work: service records, unit histories, and anything that places the veteran in a covered location and time frame.
If denied, a veteran can file a Supplemental Claim backed by new and relevant evidence, request a Higher-Level Review from a senior adjudicator, or carry the case to the Board of Veterans’ Appeals.
Since Hodgkin’s disease is covered by the Nehmer rules, some veterans (or their survivors) could obtain an effective date tied to an earlier claim or denial, resulting in years of retroactive benefits.
Board of Veterans’ Appeals Decisions on Agent Orange Hodgkin’s Claims
To see how the more complicated cases resolve, Hill & Ponton analyzed Board of Veterans’ Appeals decisions from 2021 through 2025 that specifically involved Hodgkin’s disease claimed on Agent Orange or other herbicide exposure, including claims brought by survivors over a veteran’s cause of death. The screened set held 53 Hodgkin’s decisions: 17 grants (32.1%), 15 denials (28.3%), and 21 remands (39.6%).
That remand share, close to four in ten, almost always traces back to exposure the record had not pinned down (cases involving service in Thailand, along the Korean demilitarized zone, at Fort McClellan, Fort Chaffee, Fort Gordon or Fort Dix, in the Philippines, or aboard contaminated aircraft), which the Board returned for further development before it could rule.
The denials centered around reasons such as no Hodgkin’s diagnosis actually confirmed in the file, exposure the evidence never established, a favorable medical opinion built on an exposure history no one had verified, a veteran whose cancer proved to be a different type, and a disease that surfaced long after service with neither a valid presumption nor a direct nexus.
How Does the VA Rate Hodgkin’s Disease?
Once service connection is established, Hodgkin’s is rated at 100% under Diagnostic Code 7709 while active or during treatment, for 6 months after treatment concludes. The VA then orders a mandatory examination. If the cancer is in remission by that point, the evaluation shifts to whatever residual effects remain, such as lasting harm from chemotherapy or radiation, rated under the codes that fit those problems.
Rating the Residuals of Hodgkin’s Disease
- Chronic fatigue or weakness – 10% to 100% depending on level of fatigue, strength reduction, and restriction of daily activities (often 30% to 60% when daily function is limited). This does not apply to ordinary fatigue after cancer treatment.
- Heart conditions related to treatment – 10% to 100% based on factors such as structural damage to the heart and symptoms (including shortness of breath with activity).
- Lung impairment – 0% to 100%, depending on ongoing breathing difficulties and pulmonary function testing (lung capacity and airflow measurements).
- Anemia – 0% to 100% for different types of anemia with their own diagnostic codes and criteria, such as hemoglobin levels, transfusion, or continued iron supplementation needs.
- Peripheral neuropathy – 10% to 80%, depending on the affected nerve and limb, degree of paralysis, and whether one or both sides are affected.
- Cognitive impairment – 10% to 100% for certain neurological or mental disorders involving memory problems, trouble focusing, and symptoms that interfere with work and daily responsibilities.
- Thyroid disorders caused by radiation treatment.
Get Help with Your Claim
Hill & Ponton VA-accredited attorneys focus exclusively on handling appeals for veterans and their surviving family members. If you were denied by the VA, request a free case evaluation to explore your options.
Written by
